BlackRock Investment Management, LLC - REATA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 52 filers reported holding REATA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Links
Filings
External links
Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$481,000
-16.5%
22,050
+0.8%
0.00%0.0%
Q3 2016$576,000
+33.0%
21,867
-0.3%
0.00%0.0%
Q2 2016$433,000–21,926–0.00%–
 Download
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders